Phase 3 Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who had little to no disability before their stroke (able to carry out usual activities with at most minor symptoms)
- People who have had an acute ischemic stroke (caused by a blockage) in a specific group of large blood vessels at the front of the brain, confirmed by a CT or MRI scan
- People whose stroke symptoms were measured as moderately severe or worse on a standard stroke scale at the time of hospital admission
- People who received a treatment to restore blood flow to the brain within 24 hours of the stroke starting, in line with international medical guidelines
- People whose brain scan results show that only a limited area of the brain has been severely damaged (specific scan score thresholds apply — confirm with trial site)
- For patients transferred from another hospital, the time between the brain scan and the start of the procedure must be within 3 hours
- People in whom blood flow to the brain was successfully restored (to a defined level) after treatment, confirmed by a specialised imaging procedure called a catheter angiogram
- People who are enrolled in or covered by a French social security plan
Who may not be able to join:
- People who do not speak French
- People who have certain medical conditions that make a specific type of clot-dissolving treatment (intra-arterial thrombolysis) unsafe, including very low platelet counts, certain blood-thinning medication use within 48 hours, or other blood clotting concerns (confirm with trial site for specific details)
- People who experienced complications during their stroke procedure that increase the risk of bleeding, such as a tear in the carotid artery or difficulties with the access point used for the procedure
- People who had a fall during their stroke that raises the risk of bleeding complications
- People whose stroke procedure required more than 5 thrombectomy devices (tools used to remove the clot)
- People who have bleeding inside the brain
- People who required a stent (a small tube to hold a blood vessel open) to treat a blockage or severe narrowing
- People who are not expected to be available or able to attend a follow-up visit at 3 months
- People who are currently participating in, or have participated in within the past 30 days, another clinical trial that may affect their recovery outcomes
- Women of childbearing age who are not using effective contraception
- People who fall under specific protected categories defined by the French Public Health Code (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 3 83 85 15 01
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The superiority of adjunct intra-arterial thrombolysis versus no adjunct intra-arterial thrombolysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.